Abivax SA expected to post a loss of 60 cents a share - Earnings Preview

Abivax SA

29/03/2024 16:03

* Abivax SA  ABVX.OQ   ABVX.O  is expected to report
resultson
April 2 for the period ending September 30 2023
    * 
    * ​LSEG's mean analyst estimate for Abivax SA is for a loss
of 60
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Abivax SA
is
$17.50​, above​ its last closing price of $14.30. ​​​

This summary was machine generated March 29 at 16:03 GMT.  All
figures in euros unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)